 |
Carcinoma, Hepatocellular - Blood
Research News and Information
Definition of 'Carcinoma, Hepatocellular'A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Common names: Carcinoma, Hepatocellular; Hepatocellular Carcinoma; Carcinomas, Hepatocellular; Hepatocellular Carcinomas; Hepatoma; Hepatomas |
Saturday, March 20, 2010
13 Nov 2009 
Interleukin-6 (IL-6) may play a role in the pathogenesis of hepatocellular carcinoma (HCC). Recently, it was reported in mouse models that estrogen-mediated inhibition of IL-6 production explains the gender disparity in HCC. We conducted a ... Read more...
4 Sep 2009 Hepatitis B virus X protein (HBx) plays a crucial role in the development of hepatocellular carcinoma (HCC). However, the significance of circulating antibody to hepatitis B virus X antigen (anti-HBx) in sera remains unclear. In the present study, ... Read more...
Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma.
30 Jul 2009 To identify and characterize a serologic glycoprotein biomarker for hepatocellular carcinoma (HCC), multi-lectin affinity chromatography was used to isolate intracellular N-linked glycoprotein fractions from five paired non-tumor and tumor tissues. ... Read more...
Latest indexed articles for 'Carcinoma, Hepatocellular - Blood'
These are the very latest articles for this heading:
- Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. 13 Nov 2009
- Anti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV. 4 Sep 2009
- Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. 30 Jul 2009
- Successful transcatheter chemoembolization for acute jaundice in a patient with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a case report. 30 Jul 2009
- Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma. 27 Jul 2009
- Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma. 8 Jul 2009
- Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma. 4 Jul 2009
- High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma. 29 Jun 2009
- The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom. 29 Jun 2009
- Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma. 29 Jun 2009
- Abnormal expression of fibrinogen gamma (FGG) and plasma level of fibrinogen in patients with hepatocellular carcinoma. 29 Jun 2009
- Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
29 Jun 2009 - Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma. 29 Jun 2009
- Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy. 20 Jun 2009
- TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. 19 Jun 2009
- High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. 13 Jun 2009
- Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen. 30 May 2009
- Ataxia telangiectasia with hepatocellular carcinoma.
30 May 2009 - Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis. 30 May 2009
- A patient with huge hepatocellular carcinoma who had a complete clinical response to p53 gene combined with chemotherapy and transcatheter arterial chemoembolization. 30 May 2009
See a longer list of these articles.
Technical information about 'Carcinoma, Hepatocellular'
Definition: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
Descriptor UI: D006528
Alternative terms: Carcinoma, Hepatocellular; Hepatocellular Carcinoma; Carcinomas, Hepatocellular; Hepatocellular Carcinomas; Hepatoma; Hepatomas;
Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;
Tree Number: C04.557.470.200.025.255; C04.588.274.623.160; C06.301.623.160; C06.552.697.160;
Online Note: use CARCINOMA, HEPATOCELLULAR to search HEPATOMA 1966-93
History Note: 94; was HEPATOMA 1963-93; CARCINOMA, HEPATOCELLULAR was see HEPATOMA 1991-93
Technical Notes: human & vet only: note X ref HEPATOMA: also available is HEPATOMA, EXPERIMENTAL see LIVER NEOPLASMS, EXPERIMENTAL for exper anim; coord IM with LIVER NEOPLASMS (IM)